Bevenopran

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

贝诺普兰 (Bevenopran) 是一种 μ-阿片受体外周拮抗剂，可用于治疗阿片类化合物引起的肠功能障碍的研究。

Bevenopran is a peripheral antagonist of μ-opioid receptor and can be used in studies about the treatment of opioid-induced bowel dysfunction.(In Vivo):Bevenopran tends to increase bowel movement (BM) frequency, especially for 0.1 mg twice daily and 4 mg daily, respectively.

——

Bevenopran is a peripheral μ-opioid receptor antagonist. Bevenopran is currently under investigation for the treatment of opioid-induced bowel dysfunction (OBD). Bevenopran tends to increase bowel movement (BM) frequency, especially for 0.1 mg twice daily and 4 mg daily, respectively.

CB-5945 | ADL-5945

Endocrinology/Hormones

Opioid Receptor

Acidic mammalian chitinase (AMCase)| Chitotriosidase (CHIT1)

——

——

676500-67-7

386.452

C20H26N4O4

>98% (HPLC)

In Vitro:?DMSO : 125 mg/mL (323.47 mM)

COc1cc(CNCCC2CCOCC2)ccc1Oc1cnc(cn1)C(N)=O

——

(-20℃)

With Ice Pack

≥ 2 years